Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-01-18
1998-06-16
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
057671648
ABSTRACT:
The present invention relates to the use of deprenyl or derivatives or analogues of deprenyl to rescue damaged nerve cells in an animal; to pharmaceutical compositions containing deprenyl adapted for such use; and, to methods for the treatment of disorders of the nervous system by rescuing damaged nerve cells.
REFERENCES:
patent: 4861800 (1989-08-01), Buyske
patent: 4960797 (1990-10-01), Ecsery
Merck Index, 10th edition #52876, 6902, 1983.
CA 106:168235, Youdin et al 1987.
Medline 89036757, Fuller et al, 1988.
Birkmayer, W. et al.; (1985) "Increased Life Expectancy Resulting from Addition of L-Deprenyl to Madopar.RTM. Treatment in Parkinson's Disease: A Longterm Study", J. Neural Transmission; 64; pp. 113-127.
Finnegan, Kevin T. et al.; (1990) "Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibitioin of MAO B", Euro. J. Pharmacol.; 184(1); abstract of pp. 119-126.
Greenwood, Carol E. et al.; (1991) "Increased Dopamine Synthesis in Aging Substantia Nigra Neurons"; Neurobiology of Aging; vol. 12; pp. 557-565.
Jonakait, G. Miller et al.; (1988) "Development of serotonin, substance P and thyrotrophin-releasing hormone in mouse medullary raphe grown in organotypic tissue culture: developmental regulation by serotonin"; Brain Research, 473; pp. 336-343.
Juorio, A.V. et al.; (1991) "Electrical Stimulation of the Substantia Nigra and Changes of 2-Phenylethylamine Synthesis in the Rat Striatum"; Journal of Neurochemistry; 56; pp. 213-220.
Matsui, Yoshiki and Kumagae, Yoshihiro; (1991) "Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia"; Neuroscience Letters; 126; pp. 175-178.
The Merck Index; (1983) 10th edition, Windholz, M. (Ed.), abstract 2893, p. 423, abstract 6988, p. 1023, abstract 1983; p. 282.
Rinne; (1991) "Nigral degeneration in Parkinson's disease in relation to clinical features"; Acta Neurol Scand.; 84: Supp. 136; pp. 87-90.
Rinne et al.; (1991) "Selegine (deprenyl) treatment and death of nigral neurons in Parkinson's disease"; Neurology; 41; pp. 859-861.
Seniuk et al; (1990); "Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP"; Brain Res.; 527(1); pp. 7-20.
Tatton et al.; (1992); "Interactions Between MPTP-Induced and Age-Related Neuronal Death in a Murine Model of Parkinson's Disease"; Can. J. Neurological Sciences; 19(1) (Supp.); pp. 124-133.
Tatton, W.G and Greenwood, C.E.; (1991); "Rescue of Dying Neurons: A New Action for Deprenyl in MPTP Parkinsonism"; Journal of Neuroscience Research; 30; pp. 666-672.
Tatton et al.; (1991) "Different Rates of Age-Related Loss For Four Murine Monaminergic Neuronal Populations"; Neurobiol. of Aging; 12; pp. 543-556.
Tatton et al; (1991) "Transmitter synthesis increases in substantia nigra neurons of the aged mouse"; Neuroscience Letters; 131; pp. 179-182.
Tatton et al; (1990); "MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells"; Brain Res.; 527(1); pp. 21-31.
Timar, Julia; (1989) "Recovery of Mao-B Enzyme Activity After (-)Deprenyl (Selegiline) Pretreatment, Measured in Vivo"; Acta Physiologica Hungarica; vol. 74(3-4); pp. 259-266.
Torok, Tamas L. et al; (1987) "Transmitter releasing action of selegiline ((-)-deprenyl) from peripheral sympathetic nerves under different experimental conditions"; J. Pharm. Pharmacol.; 39(10); abstract of pp. 797-802, p. 48 of Chemical Abstracts.
Zsilla, Gabriella et al.; (1984) "Neurochemical evidences for facilitation of dopaminergic function in rat brain by repeated doses of (-) deprenyl"; Dev. Neurosci. (Amsterdam); 17 (Regular Transm. Funct.: Basic Clin. Aspects); abstract of pp. 345-348; p. 64 of Chemical Abstracts.
Zsilla, Gabriella et al.; (1986) "The Effect of Repeated Doses of (-) Deprenyl On The Dynamics of Monoaminergic Transmission. Comparison With Clorgyline"; Pol. J. Pharmacol. Pharm.; 38; pp. 57-67.
Zsilla, Gabriella et al.; (1983) "(-)-Deprenyl A Selective Mao `B` .beta.-Adrenergic Receptor Function", European Journal of Pharmacology; 89; pp. 111-117.
Zsilla, G. and Knoll, J.; (1982) "The Action of (-)Deprenyl on Monamine Turnover Rate in Rat Brain"; Typical and Atypical Antidepressants: Molecular Mechanisms; pp. 211-217.
Greenwood Carol E.
Tatton William G.
Cook Rebecca
Hanley Elizabeth A.
Innovations Foundation
Russett Mark D.
LandOfFree
Use of deprenyl to rescue damaged nerve cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of deprenyl to rescue damaged nerve cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of deprenyl to rescue damaged nerve cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726527